Literature DB >> 30630006

PES1 enhances proliferation and tumorigenesis in hepatocellular carcinoma via the PI3K/AKT pathway.

Jing Wang1, Jie Sun1, Na Zhang1, Renjun Yang1, Huixian Li1, Yujue Zhang1, Keyang Chen2, Derun Kong3.   

Abstract

AIM: We investigated the potential role of pescadillo ribosomal biogenesis factor 1 (PES1) in the development of hepatocellular carcinoma (HCC).
MATERIAL AND METHODS: One hundred and thirty-four patients with hepatocellular carcinoma were chosen to evaluate the association between the expression of PES1 and survival, clinical characteristics of these patients. Western blotting, real-time PCR, immunohistochemistry, CCK-8 assay, colony formation and subcutaneous tumors in nude mice were conducted. KEY
FINDINGS: We found that PES1 was commonly upregulated in HCC tissues and cells. Immunohistochemical analysis of 134 paraffin-embedded archived HCC tissues showed that the protein expression level of PES1 was positively correlated with clinical characteristics and reduced the survival time of HCC patients. Univariate and multivariate analysis revealed that PES1 expression may be an independent prognostic indicator of poorer overall survival in HCC patients. Furthermore, silencing of endogenous PES1 significantly inhibited the proliferation and tumorigenicity of SMMC 7721 and HepG2 cells in vitro as well as in vivo in nude mice. Finally, we found that PES1 affected cell proliferation by regulating the PI3K/AKT/GSK3β/cyclinD1 signaling pathway. SIGNIFICANCE: Our data suggest that PES1 may promote proliferation and tumorigenicity, and potentially representing a novel prognostic marker for overall survival in HCC. CORE TIP: We report that pescadillo ribosomal biogenesis factor 1 (PES1) plays an oncogenic role in hepatocellular carcinoma, which was commonly upregulated in hepatocellular carcinoma tissues and cells. Immunostaining analysis found that the protein expression level of PES1 was positively correlated with clinical characteristics and reduced survival time of hepatocellular carcinoma patients. Multivariate analysis revealed that PES1 expression might be an independent prognostic indicator of survival in hepatocellular carcinoma patients. Furthermore, PES1 knockdown inhibited the proliferation and tumorigenesis in hepatocellular carcinoma cell lines. Additionally, we found that PES1 is involved in the cell proliferation by regulating the AKT/GSK3β/cyclinD1 signaling pathway.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKT; Hepatocellular carcinoma; PES1; PI3K; Pescadillo; Proliferation

Mesh:

Substances:

Year:  2019        PMID: 30630006     DOI: 10.1016/j.lfs.2018.12.054

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  PES1 In Liver Cancer: A Prognostic Biomarker With Tumorigenic Roles.

Authors:  Zhuo Fu; Yan Jiao; Yan-Qing Li; Jian-Ji Ke; Yan-Hui Xu; Bao-Xing Jia; Bin Liu
Journal:  Cancer Manag Res       Date:  2019-11-14       Impact factor: 3.989

2.  Long non‑coding RNA HOXA11‑AS accelerates cell proliferation and epithelial‑mesenchymal transition in hepatocellular carcinoma by modulating the miR‑506‑3p/Slug axis.

Authors:  Yinghui Liu; Wenzhao Yan; Dongfang Zhou; Guohua Jin; Xin Cheng
Journal:  Int J Mol Med       Date:  2020-08-28       Impact factor: 4.101

3.  SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and miR-339-5p-FOSL2-SNHG17 positive feedback loop.

Authors:  Zehua Bian; Mingyue Zhou; Kaisa Cui; Fan Yang; Yulin Cao; Shengbai Sun; Bingxin Liu; Liang Gong; Jiuming Li; Xue Wang; Chaoqun Li; Surui Yao; Yuan Yin; Shenglin Huang; Bojian Fei; Zhaohui Huang
Journal:  J Exp Clin Cancer Res       Date:  2021-11-15

4.  Upregulation of GTPBP4 Promotes the Proliferation of Liver Cancer Cells.

Authors:  Jia Chen; Jie Zhang; Zhiwei Zhang
Journal:  J Oncol       Date:  2021-10-19       Impact factor: 4.375

5.  Gene Expression Characteristics of Liver Tissue Reveal the Underlying Pathogenesis of Hepatocellular Carcinoma.

Authors:  Congfang Guo; Xiang Guo; Yudong Rong; Yirui Guo; Li Zhang
Journal:  Biomed Res Int       Date:  2021-10-04       Impact factor: 3.411

Review 6.  The functional role of Pescadillo ribosomal biogenesis factor 1 in cancer.

Authors:  Yong-Zhi Li; Cheng Zhang; Jun-Peng Pei; Wan-Chuan Zhang; Chun-Dong Zhang; Dong-Qiu Dai
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

7.  Rcl1 suppresses tumor progression of hepatocellular carcinoma: a comprehensive analysis of bioinformatics and in vitro experiments.

Authors:  Yu Jiaze; Hou Sinan; Yang Minjie; Zhou Yongjie; Du Nan; Wang Liangwen; Zhang Wen; Luo Jianjun; Yan Zhiping
Journal:  Cancer Cell Int       Date:  2022-03-09       Impact factor: 5.722

Review 8.  Enabling factor for cancer hallmark acquisition: Small nucleolar RNA host gene 17.

Authors:  Ningzhi Zhang; Yuanyuan Sun; Tuo Wang; Xinyuan Xu; Mengru Cao
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

9.  PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer.

Authors:  Xin Jin; Rui Fang; Ping Fan; Lipeng Zeng; Bin Zhang; Xiaoming Lu; Tao Liu
Journal:  J Exp Clin Cancer Res       Date:  2019-11-12

10.  The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer.

Authors:  Lei Zhang; Yidong Li; Qianchao Wang; Zhuo Chen; Xiaoyun Li; Zhuoxun Wu; Chaohua Hu; Dan Liao; Wei Zhang; Zhe-Sheng Chen
Journal:  Mol Cancer       Date:  2020-01-17       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.